PROM1 and neoplasm: The enhanced ability of CD44+CD133+ tumor-initiating cells of primary xenografts to initiate tumor formation may be related to the abundance of CD44+CD133+ tumor-initiating cells in secondary xenografts after injection of NSG mice or Wnt/β-catenin signaling may be further activated in CD44+CD133+ cells in secondary xenografts.